Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04102566 · ClinicalTrials.gov registry record · Phase 4

Optimizing Pain Control in Transurethral Resection of the Prostate

A Phase 4 study of Pain and BPH With Urinary Obstruction, sponsored by Benaroya Research Institute.

Recruiting
Registry status
Phase 4
Development phase
50
Enrollment target
1
Study location

NCT04102566 is a Phase 4 study of Pain and BPH With Urinary Obstruction that is actively recruiting participants, run by Benaroya Research Institute. The registered enrollment target is 50 participants, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04102566, a Phase 4 study of Pain and BPH With Urinary Obstruction, is actively recruiting participants, sponsored by Benaroya Research Institute.

RECRUITING
Registry status
Phase 4
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to develop a multi-modal protocol for pain management after TURP that minimizes opioid use. The investigators hypothesize this approach will provide non-inferior pain control to the current standard of care which includes opioids as the primary agent. The investigators believe this is an important step in reducing the opioid epidemic in surgical patients.

Interventions

  • DRUG Ibuprofen 600 mg
  • BEHAVIORAL Education

Study Locations (1)

Washington

  • Virginia Mason Medical Center - Seattle

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2017-12-08
Est. Completion 2019-12-01
Phase Phase 4

Sponsor

Benaroya Research Institute

28 total trials

What the Registry Record Tells You About NCT04102566

The ClinicalTrials.gov registry entry for NCT04102566 describes a study currently listed as recruiting, categorized as Phase 4. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 304-participant average among 374 other Pain trials with a reported enrollment target (84% lower). The listed sponsor is Benaroya Research Institute, which has 28 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Pain appearing as the primary indexed condition, and to 2 interventions - of which Ibuprofen 600 mg is the first listed.

NCT04102566 reports 1 study location spanning 1 distinct geographic area - top geographies include Washington.

Frequently Asked Questions

What is clinical trial NCT04102566 about?

NCT04102566 is a clinical study titled "Optimizing Pain Control in Transurethral Resection of the Prostate". The purpose of this study is to develop a multi-modal protocol for pain management after TURP that minimizes opioid use. The investigators hypothesize this approach will provide non-inferior pain control to the current standard of care which includes opioids as the primary agent. The investigators b...

What is the current status of trial NCT04102566?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 50 participants. The study started on 2017-12-08. Estimated completion is 2019-12-01.

What conditions does trial NCT04102566 study?

This clinical trial studies the following conditions: Pain, BPH With Urinary Obstruction, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms.

What interventions are being tested in trial NCT04102566?

The interventions under investigation include: Ibuprofen 600 mg (DRUG), Education (BEHAVIORAL).

Who is sponsoring clinical trial NCT04102566?

This trial is sponsored by Benaroya Research Institute, which has 28 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04102566 being conducted?

This trial has 1 study location across Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.